Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renhetang Pharmaceutical is a venerable Chinese pharmaceutical enterprise recognized as a China Time-honored Brand with roots tracing back to 1607. The company specializes in the research, development, and large-scale manufacturing of Traditional Chinese Medicine (TCM) and modern over-the-counter (OTC) medications. Its extensive product portfolio covers therapeutic areas such as respiratory health, gastroenterology, and cardiovascular disease, featuring well-known products like Ganmao Qingre Granules. Currently operating as a key subsidiary of the publicly traded Renhe Pharmacy Co., Ltd., Renhetang maintains advanced GMP-certified facilities in Shandong Province. The company is dedicated to modernizing traditional herbal formulations through rigorous quality control and contemporary pharmacological research. Its products are widely distributed across China, serving as a staple in domestic household medicine cabinets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Renhetang Pharmaceutical.